Opioid Hysteria and the Demonizing of Dsuvia

Opioid Hysteria and the Demonizing of Dsuvia: By John Burke, Guest Columnist Recently the FDA approved a new sublingual formulation of sufentanil -- called Dsuvia -- for the management of moderate to severe acute pain in hospital-like settings. This would include surgical centers and emergency departments. When the FDA announced this appro